Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas

Tumor Treating Fields (TTFields) were incorporated into the treatment of glioblastoma, the most malignant brain tumor, after showing an effect on progression-free and overall survival in a phase III clinical trial. The combination of TTFields and an antimitotic drug might further improve this approa...

Descripción completa

Detalles Bibliográficos
Autores principales: Krex, Dietmar, Bartmann, Paula, Lachmann, Doris, Hagstotz, Alexander, Jugel, Willi, Schneiderman, Rosa S., Gotlib, Karnit, Porat, Yaara, Robel, Katja, Temme, Achim, Giladi, Moshe, Michen, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003311/
https://www.ncbi.nlm.nih.gov/pubmed/36902447
http://dx.doi.org/10.3390/ijms24055016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003311/
https://www.ncbi.nlm.nih.gov/pubmed/36902447
http://dx.doi.org/10.3390/ijms24055016

Ejemplares similares